Dornier MedTech names new general manager for Dornier MedTech America

KENNESAW, GA – Janaury 17, 2001 – Dornier MedTech has recently named Brian Walsh as its new general manager of Dornier MedTech America (DMT America).

Prior to his appointment, Walsh served as vice president of international marketing for Dornier MedTech GmbH, the parent company of DMT America.

Walsh holds a master’s degree in business administration from the Goizueta Business School at Emory University in Atlanta, Ga., as well as a master’s and bachelor’s degree in bioengineering from the University of California, San Diego. Prior to joining Dornier, Walsh held various marketing, planning and product development positions at leading diagnostic and therapeutic medical device organizations.

"I’m pleased and certainly thrilled to be taking on this new role," Walsh said. "Dornier has a strong history, a fantastic reputation and a dominant presence in many areas of the world. We’re dedicated to addressing customer needs through a broad portfolio of innovative products, including an array of lithotripters, fluoroscopic urology tables, lasers and imaging devices, as well as variety of lifestyle enhancing orthopedic, dermatologic
and cosmetic surgery applications."

DMT America is a subsidiary of Munich-based Dornier MedTech, which pioneered the development of extracorporeal shockwave lithotripsy 20 years ago. Dornier has the largest installed base of over 1,000 lithotripters internationally. DMT America markets and services Dornier products in North America .

Today, Dornier MedTech has operating units and service partners throughout the world and continues to maintain its commitment to the health-care industry by providing innovative therapeutic, diagnostic and service solutions for numerous medical fields.

Dornier MedTech’s principal shareholders are Singapore Technologies and DaimlerChrysler.